Trial Registration Number: IRCT20111224008505N47.ĭiabetes Mellitus is a worldwide metabolic disease and becomes a challenge for the health practitioner. Thus, further larger studies are recommended to evaluate the effectiveness of this technique. In sum, the study indicated that acupressure could only be effective in reducing the glycosylated hemoglobin in the intervention group. However, a significant difference was observed in the intervention group's glycosylated hemoglobin mean levels before (8.61☑.96) and after the intervention (8.1☑.62) (P=0.02). The results showed no significant differences among the three groups' blood glucose mean levels before (P=0.89) and after the intervention (P=0.36). The data were analyzed using Chi-square, paired t-test, and ANOVA by the SPSS statistical software, version 21, and P<0.05 was considered statistically significant. Fasting blood glucose and glycosylated hemoglobin levels were checked in all patients immediately after the intervention. The intervention was carried out for six minutes (three minutes for each lower extremity), three sessions a week for 12 weeks. The placebo group also received medications and acupressure at a fake point. The intervention group received acupressure at ST36 point in addition to medications. The control group only received the pharmacological treatments. The participants were selected based on simple random sampling and divided into three groups via permuted block randomization.
#KID3 ACUPUNCTURE POINT LOCATIONI TRIAL#
This clinical trial was conducted on 102 patients who referred to Motahari Clinic of Shiraz during May-June in 2018. The present study aimed to investigate the effect of acupressure point on fasting blood glucose and glycosylated levels of diabetic patients. Non-pharmacological methods can be used for treatment of these patients. Thus, we propose that neuroimaging studies can be used in diagnosis and treatment of sleep disorders in T2DM.ĭiabetes is the most common endocrine disorder. DTI and fMRI can map the human brain and are utilized in many experiments. Neuroimaging studies of these disorders can achieve higher treatment efficacy by targeting brain areas, such as the hypothalamus, as visualized via diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI). Standard and alternative treatments for T2DM were somehow effective in treating SD. Generalized treatment methods for T2DM include dietary/weight-loss management, metformin or a combination of two non-insulin drugs and melatonin for SD, although alternative therapies including electroacupuncture (EA) have been utilized in treating both of these diseases separately because they are convenient, affordable, and safe. The bibliographic databases PubMed and Web of Science were searched for relevant articles published between January 2002 and September 2021. This review assesses current clinical and neuroimaging findings to develop alternative targeted treatments for curing T2DM and sleep disorders. The brains of individuals who suffer from both diseases simultaneously might be different compared to healthy individuals. Both are common diseases related to brain functional and structural abnormalities involving the hypothalamic-pituitary-adrenal (HPA) axis. Type 2 diabetes mellitus (T2DM) and sleep disorders (SD) have become important and costly health issues worldwide, particularly in China.
0 kommentar(er)
